Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Citizin Q10
- Development stage
- Unknown
- Lead developer
- Bruschettini
- Administration
- Oral
01
Overview
Citizin Q10 is an ophthalmic nutraceutical developed and marketed by Bruschettini. It is formulated as a dietary supplement to support the metabolism and structural integrity of nerve cells, particularly retinal ganglion cells and photoreceptors, helping to maintain visual function efficiency. The product contains a combination of citicoline (Cognizin), coenzyme Q10, vitamins A, C, E, and B-complex (B1, B2, B6, B12, biotin), and blackcurrant (Ribes nigrum) anthocyanosides. It is indicated as a supportive therapy for visual impairment, glaucoma, and optic neuropathy, providing antioxidant protection against oxidative stress and supporting mitochondrial energy metabolism. It is available in oral formulations, including liquid vials and orosoluble stick packs (Citizin Q10 Oro).
- Brand names
- Citizin Q10Citizin Q10 Oro
- Other names
- citicoline + coenzyme Q10 + vitamins + blackcurrant anthocyanosides
02
Targets
FGF2QcrB (Cytochrome b)MAOA (Monoamine oxidase A)PCYT1A (Phosphate cytidylyltransferase 1, choline-alpha)PCYT1B (Choline-phosphate cytidylyltransferase beta)OCT2 (Organic cation transporter 2)
Beyond the preview
Go deeper on Citizin Q10.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Citizin Q10.